Health is Nextwave X Partners’ broadest theme — life sciences, biotech, oncology, obesity, women’s health, and the operator surface that connects them. Our health theme is co-founded by Chuck Ryan, MD — the GU oncologist who directed the abiraterone (Zytiga) development program, ran the Prostate Cancer Foundation, and now leads 1:8 Ventures with us. Around him: KOLs across cancer, obesity, and women’s health, a live health-summit engagement layer, and the full spectrum of positions from LP to advisory to direct.
Most oncology theme leaders are financial. NXP’s Health theme is co-founded by the physician-scientist who ran the pivotal program and led the foundation.
Health is not a single specialty. NXP’s KOL bench spans oncology, obesity medicine, and women’s health — the three surfaces of health where category economics are being redrawn right now.
The full cancer KOL roster — clinicians, principal investigators, and category advisors — lives on the 1:8 Ventures site. Every cancer position under NXP Health is filtered through this bench.
The community-medicine vantage point. Joanna sees the obesity epidemic as it actually presents in day-to-day practice — GLP-1 access, adherence, insurance friction, patient education, and the long tail after the prescription. Uniquely instructive because she has been on the entrepreneurial side too, having developed a product idea inside the specialty. Community-practice reality plus operator lens on the largest single-condition category in modern medicine.
The corporate + concierge vantage point. Meagan built the concierge and on-site primary-care model through One Medical at SpaceX — direct exposure to how one of the most demanding employers in the world buys and manages healthcare. She now runs a full-spectrum women’s-health practice centered on peri- and menopause care — the category most underinvested and being remade fastest. Employer economics plus underserved-category clinical leadership under one KOL.
One section instead of two. Each row is a piece of the operating and clinical experience we’re building the Health theme on — and the vehicle that experience now travels through. The evidence and the engagement mechanism, side by side, so an LP or partner can see both at once instead of flipping between a track-record page and a spectrum page.
Everything above becomes the raw material under these three vehicles. Each one is live today, has a real front door, and takes a different kind of partner from the same LP/GP/operator table.
Prostate-cancer venture platform led by Chuck Ryan and the oncology KOL bench. The rare fund where the GP ran the trials that set the standard of care — not just adjacent to the science, on it. Currently in formation; LP and co-invest conversations live.
The recurring, on-the-record convening surface for the Health theme — patients, KOLs, operators, pharma innovation groups, and allocators in the same room. The engagement layer that grounds every position downstream, and the fastest way for a partner to see the bench.
Starting or advising early-stage health companies where the operator experience above becomes an actual cap table — sometimes as founding capital, sometimes as advisory-to-equity, always with a real operator on the inside.
LP positions into 1:8 Ventures and the specialist managers on our shortlist. Strategic engagement for pharma and consumer-health innovation groups. Advisory partnerships with clinicians and operators building the next standard of care. A seat at the NXP Health Innovations Summit for institutions and families with a health thesis. Start the conversation→